Piermont Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Piermont Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-9,420	Closed	-$927K	–	237
2018 Q2	$927K	Sell	9,420 -540	-5%	-$60.4K	0.28%	118
2018 Q1	$1.11M	Sell	9,960 -650	-6%	-$72.9K	0.37%	111
2017 Q4	$1.09M	Sell	10,610 -230	-2%	-$22.9K	0.36%	109
2017 Q3	$1.02M	Sell	10,840 -9,280	-46%	-$732K	0.34%	110
2017 Q2	$1.57M	Buy	20,120 +12,110	+151%	+$910K	0.45%	95
2017 Q1	$642K	Hold	8,010	–	–	0.15%	210
2016 Q4	$631K	Hold	8,010	–	–	0.14%	207
2016 Q3	$625K	Hold	8,010	–	–	0.15%	217
2016 Q2	$551K	Buy	+8,010	New	+$553K	0.14%	222
2014 Q4	–	Sell	-10,470	Closed	-$360K	–	212
2014 Q3	$360K	Buy	10,470 +4,670	+81%	+$165K	0.14%	124
2014 Q2	$212K	Buy	+5,800	New	+$197K	0.08%	127

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Piermont Capital Management's CMD Position: Q3 2018 in Review

Piermont Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 9,420 shares — an estimated $927K sold.

Piermont Capital Management first reported a position in CMD in Q2 2014 and held it in 11 quarters. The position peaked at $1.57M in Q2 2017. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

Piermont Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
Piermont Capital Management sold 9,420 Cantel Medical Corporation shares in Q3 2018, an estimated $927K.
Piermont Capital Management first reported a position in Cantel Medical Corporation in Q2 2014 and held it in 11 quarters.
Piermont Capital Management's Cantel Medical Corporation position peaked at $1.57M in Q2 2017.
286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.